Recalls / Class III
Class IIID-0073-2023
Product
Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India
- Affected lot / code info
- Lot# (a) AC2203133B, EXP 01/2024; (b) AC2203133A, EXP 01/2024.
Why it was recalled
Failed dissolution specifications
Recalling firm
- Firm
- Dr. Reddy's Laboratories, Inc.
- Notification channel
- Letter
- Address
- 107 College Rd E, Princeton, New Jersey 08540-6623
Distribution
- Quantity
- 25,176, 30-count; 22,968 20-count
- Distribution pattern
- Nationwide in the USA
Timeline
- Recall initiated
- 2022-11-21
- FDA classified
- 2022-11-30
- Posted by FDA
- 2022-12-07
- Terminated
- 2024-08-28
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0073-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.